Literature DB >> 6174520

Developmental expression of murine extra-embryonic endodermal cytoskeletal proteins.

R G Oshima.   

Abstract

Murine extra-embryonic endodermal cell lines derived from either teratocarcinomas or mouse embryos contain a cytoskeletal protein (Endo A) of Mr = 55,000. Endo A was immunoprecipitated from [35S]methionine-labeled lysates of three parietal endodermal cell lines, A presumptive visceral endodermal cell line, and a fetal hepatoma cell line, but not from fibroblasts, myoblasts, erythroleukemic cells, neuroblastoma cells, keratinocytes, or embryonal carcinoma cells. Embryonal carcinoma cells induced to differentiate by exposure to retinoic acid synthesized increased amounts of Endo A approximately 48 h after exposure to the inducer. Two-dimensional gel analysis of immunoprecipitated samples confirmed that Endo A is distinct from vimentin and murine keratinocyte proteins recognized by two different keratin antisera. Comparison by two-dimensional gel electrophoresis of immunoprecipitated Endo A labeled with either [35S]methionine or [32P]orthophosphate indicated that the multiple forms of Endo A resolved by isoelectric focusing were due, at least in part, to phosphorylation. Serine was identified as the phosphorylated amino acid. Endo A was the only major antigenic protein found in a parietal endodermal cell line which was recognized by a monoclonal antibody prepared by other investigators against trophoblast cytoskeletons. The results indicate that Endo A, like the previously described Endo B protein, is distinct from other cytoskeletal proteins and will be useful as a marker of the differentiation of murine embryonal carcinoma cells to extra-embryonic endoderm.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174520

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Methylation of an ETS site in the intron enhancer of the keratin 18 gene participates in tissue-specific repression.

Authors:  A Umezawa; H Yamamoto; K Rhodes; M J Klemsz; R A Maki; R G Oshima
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Type II keratins are phosphorylated on a unique motif during stress and mitosis in tissues and cultured cells.

Authors:  Diana M Toivola; Qin Zhou; Luc S English; M Bishr Omary
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

3.  Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells.

Authors:  J R Flanagan; M Murata; P A Burke; Y Shirayoshi; E Appella; P A Sharp; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 4.  Intermediate filaments: a historical perspective.

Authors:  Robert G Oshima
Journal:  Exp Cell Res       Date:  2007-04-11       Impact factor: 3.905

5.  Lamellar cells of sensory receptors and perineural cells of nerve endings of pig skin contain cytokeratins.

Authors:  J P Ortonne; P Verrando; G Pautrat; M Darmon
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

6.  Suppression of endo B cytokeratin by its antisense RNA inhibits the normal coexpression of endo A cytokeratin.

Authors:  K Trevor; E Linney; R G Oshima
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

Review 7.  Oncogenic regulation and function of keratins 8 and 18.

Authors:  R G Oshima; H Baribault; C Caulín
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

Review 8.  Implications of intermediate filament protein phosphorylation.

Authors:  N O Ku; J Liao; C F Chou; M B Omary
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

9.  One gene and one pseudogene for the cytokeratin endo A.

Authors:  M Vasseur; P Duprey; P Brûlet; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

10.  cis regulation of the keratin 18 gene in transgenic mice.

Authors:  N S Neznanov; R G Oshima
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.